Full-Time

Director – VIM Finance

Posted on 11/22/2025

Ventas Inc

Ventas Inc

501-1,000 employees

Healthcare real estate investment trust leasing facilities

Compensation Overview

$180k - $240k/yr

+ Discretionary Incentive Compensation

No H1B Sponsorship

Louisville, KY, USA + 2 more

More locations: Chicago, IL, USA | New York, NY, USA

Hybrid

Category
Finance & Banking (1)
Requirements
  • Bachelor’s degree in Accounting or Finance.
  • CPA designation with 10+ years of relevant professional accounting experience in financial services, private equity, or a top-tier accounting firm, with specialization in investment partnerships, hedge fund of funds, mutual funds, or private equity.
  • Prior fund or private equity experience with extensive experience managing reporting and compliance in accordance with technical guidance, joint venture agreements and debt agreements
  • Must be located in the Chicago, IL, Louisville, KY, or New York, New York surrounding area or willing to relocate for the duration of employment.
  • Willingness to adapt and thrive in a blended work environment with 3-days in office, seamlessly transitioning between remote work and in-office operations.
  • Proven ability as a team player, self-starter, and independent thinker with sound judgment and logical reasoning.
  • Strong track record of success in dynamic, fast-paced environments requiring flexibility, accuracy, and attention to detail.
  • Forward-thinking leader with the ability to drive change, improve processes, create efficiencies, and deliver results to business partners.
  • High energy, positive attitude, and ability to manage multiple deadlines, competing priorities, and pressure with minimal supervision.
  • Excellent interpersonal skills, with the ability to interact professionally across all levels of the organization, including senior management and joint venture partners.
  • Proficiency in Microsoft Excel, PowerPoint, financial analysis software, and related tools.
  • Must be legally authorized to work in the United States without need for employer sponsorship now or in the future
Responsibilities
  • Support VIM CFO in capital planning; equity / debt funding sources, maturity profile, interest rate risk, etc.
  • Manage investor capital calls, redemption queue, compliance, transfers and related documentation
  • Responsible for all FP&A activity including internal Ventas’s budget and reforecast and annual investor budget requirements
  • Review of financial and investor reporting drawing on industry experience in process to ensure compliance with venture and investor compliance
  • Work with VIM accounting team on complex and high-profile transactions to support and review proper legal and accounting treatment
  • Manage cash position and distributions across ventures
  • Work closely with the Capital Markets team, taking ownership of the following: Covenant compliance review and forecasted compliance including working with asset management on changing leasing assumptions and their implications, Develop financing models and financials analysis supporting financing activity including impact on each venture and Ventas
  • Develop and review long-term forecasts used in appraisals ensuring the latest leasing / occupancy, rate and capital need assumptions are reasonable for accurate appraisals
  • Support portfolio management in various areas such valuation review, capital raising / investor presentations/meetings, and answering investor questions
  • Work with team on major quarterly, annual and ad hoc investor meeting materials and presentations including Ventas board materials
  • Manage the Fund’s credit facility compliance including reviewing covenant calculations and entity compliance
  • Drive continuous improvement within the team through process and technology enhancement projects
  • Streamlined team allows for constant interaction across all VIM activities, ability to suggest additional projects and become responsible for executing them
Desired Qualifications
  • Experience with Yardi, Longview Close, and/or Vena is a plus

Ventas, Inc. is a real estate investment trust (REIT) focused on healthcare properties. It buys, manages, and leases facilities like senior living communities, medical office buildings, life science centers, and hospitals to healthcare providers and institutions. The company generates income mainly from rental payments and benefits from property value appreciation. It operates across the US, Canada, Mexico, and the UK, leveraging partnerships with care providers, developers, research and medical institutions to create a diversified portfolio. This diversification helps smooth cash flows across economic cycles. The goal is to deliver steady, growing dividends to shareholders by maintaining a high-quality portfolio and strong balance sheet while partnering with industry leaders.

Company Size

501-1,000

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

1983

Simplify Jobs

Simplify's Take

What believers are saying

  • JPMorgan Chase holds 7.1% stake after Ventas raises 2026 guidance to $0.56-$0.63.
  • Ventas acquired $550M MOB portfolio in Q1 2026 at low 6% cap rate.
  • Aging U.S. population doubles by 2060, boosting senior housing and MOB demand.

What critics are saying

  • Welltower grabs prime senior housing, eroding Ventas market share in 12-24 months.
  • Fed high rates at 5.25-5.50% raise Ventas refinancing costs, cut NOI 15-20%.
  • Teladoc telemedicine expansion crashes Ventas MOB occupancy to 75% in 24-36 months.

What makes Ventas Inc unique

  • Ventas manages 1,400 healthcare properties across U.S., Canada, and U.K.
  • Ventas Investment Management platform attracts institutional capital for longevity economy.
  • Debra A. Cafaro leads Ventas as CEO since 1999, driving S&P 500 status.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Flexible Work Hours

Company News

RAD Commercial Realty
Apr 5th, 2026
Life sciences & MOB: resilient demand amidst rate volatility.

Life sciences & MOB: resilient demand amidst rate volatility. April 4, 2026 Majid Radaei, RadCRE Steady outperformance of healthcare and life sciences real estate. The commercial real estate landscape in late 2025 and early 2026 continues to be shaped by elevated interest rates and persistent - albeit moderating - inflation. Within this climate, the life sciences and medical office building (MOB) sectors have demonstrated remarkable resilience, attracting significant investor capital due to their defensive characteristics and strong underlying demand drivers. According to recent reports from CBRE and Real Capital Analytics (RCA), investment volume in these specialized sectors has remained robust. In Q4 2025 alone, the combined transaction volume for life sciences and MOB properties topped an estimated $8.5 billion, a notable figure given the broader slowdown in other asset classes. This sustained demand is underpinned by an aging population, advances in medical technology, and substantial R&D funding, particularly in the pharmaceutical and biotech industries. Key drivers and market activity. Demographic tailwinds are a primary catalyst for MOBs. The U.S. population aged 65 and older is projected to nearly double by 2060, significantly increasing the need for outpatient facilities and specialized healthcare services. This predictability of demand makes MOBs attractive to institutional investors seeking stable, long-term income streams. For instance, Ventas, a leading healthcare REIT, recently announced an acquisition of a portfolio of core MOBs for approximately $550 million in Q1 2026, targeting an initial cap rate in the low 6% range, showcasing continued appetite for quality assets. The life sciences sector, while more cyclical, benefits from consistent innovation and a growing pipeline of biotechnological breakthroughs. Major hubs such as Boston-Cambridge, the San Francisco Bay Area, and San Diego continue to command premium rents and low vacancy rates. In Q4 2025, CoStar reported vacancy rates for lab space in Cambridge, MA, hovering around 4.5%, with average asking rents reaching upward of $105 per square foot (NNN) for prime space. Recent noteworthy transactions include BioMed Realty's continued expansion in the Boston market, with the acquisition of a development site for a new research facility in early 2026, further solidifying the sector's growth trajectory. Capital markets nuances. While demand is strong, financing for these specialized assets still navigates a higher interest rate environment. Lenders, including major banks and debt funds, are showing a preference for sponsors with a proven track record and properties with strong tenancy and long lease terms. Bridge loans for value-add MOB plays are typically priced around SOFR + 350-550 bps, while stabilized, core MOB assets might see agency or CMBS debt at spreads of T + 175-275 bps, depending on LTV and DSCR. Life sciences development, with its higher speculative risk profile, often relies on a more complex capital stack, involving significant equity and sometimes mezzanine debt pricing in the 14-18% range. The RadCRE perspective. Majid Radaei, Founder of RAD Commercial Realty, notes, "The resilience of life sciences and medical office buildings isn't just about demographics; it's about essential services and innovation that cannot be easily disrupted by economic cycles or e-commerce trends. Lenders and investors are now more granular in their underwriting, scrutinizing tenant credit, lease structures, and the functional obsolescence of older facilities. We're seeing robust demand for both new, purpose-built facilities that meet stringent lab requirements and well-located MOBs within growing healthcare networks. The perceived stability of these cash flows offers a compelling counter-cyclical hedge, making them prime targets for institutional capital even when broader markets face headwinds." RadCRE's team of specialists across various asset classes provides expert advisory services in the acquisition, disposition, and financing of these complex properties, leveraging its deep market insights and financial modeling capabilities to structure optimal transactions for its clients. Whether it's sourcing advantageous financing for a cutting-edge lab facility or identifying value-add MOB opportunities, RadCRE assists clients in navigating this dynamic sector. Sources: CBRE Research, Real Capital Analytics (RCA), CoStar, Ventas Press Releases Evaluate your CRE Deal with AI. Get instant property valuations, sell-vs-refinance analysis, and market comps powered by its AI Deal Evaluation Platform - free for all asset classes.

TradingView
Sep 25th, 2025
Ventas Stock Rallies 16.3% Year to Date: Will the Trend Last?

In July 2025, Ventas sold three properties in its OM&R segment for $9.4 million and acquired five senior housing communities as part of its SHOP segment for $147.7 million.

Yahoo Finance
Sep 8th, 2025
Ventas to Participate in Investor Meetings at BofA Securities 2025 Global Real Estate Conference

CHICAGO, September 08, 2025-(BUSINESS WIRE)-Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") announced today that management will participate in investor meetings at the BofA Securities 2025 Global Real Estate Conference (the "BofA Securities Conference") on September 10, 2025 and will make a presentation at 3:45 p.m. Eastern Time.

Long Island Business News
Aug 25th, 2025
Global REIT buying six Long Island senior housing properties

Chicago-based Ventas, a publicly traded real estate investment trust, is acquiring six senior housing properties on Long Island for more than $600 million, according to Bloomberg.

Yield PRO
Aug 19th, 2025
Ventas Acquires 148-Unit Senior Living Center for $54M in Everett Washington

MorningStar Senior Living announced a new relationship with Ventas, Inc., with Ventas acquiring a 148-unit complex in Everett for $54.7 million.

INACTIVE